MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

MDSpire News

  • August 7, 2026
Surgical Site May Raise Infection Risk After Firearm Injury
  • Andrea Surnit
  • August 7, 2026
  • 3 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 7, 2026
Differing Admission, Testing Patterns Based on Physician Sex
  • Meg Barbor
  • August 7, 2026
  • 5 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 7, 2026
Pediatricians and Health Departments Sidestep Trump’s CDC on Vaccine Guidance
  • Karen Brown
  • New England Public Media
  • August 7, 2026
  • 8 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 7, 2026
Cleveland Clinic's AI Summit: Explore the Future of AI-Driven Health Care
  • MDSpire News Staff
  • August 7, 2026
  • 3 min
  1. Cleveland Clinic will host the Second AI Summit for Healthcare Professionals on August 28, 2026, in collaboration with CHIME.
  2. The summit aims to explore advancements and challenges in AI-driven healthcare through discussions and educational sessions.
  3. Attendees will include healthcare professionals, educators, and leaders interested in the impact of AI in healthcare.
  4. Topics will cover AI fundamentals, ethical considerations, regulatory frameworks, and emerging trends in healthcare technology.
  5. The event is designated for a maximum of 5.75 AMA PRA Category 1 Credits™ for participating physicians.
...more

MDSpire News

  • August 7, 2026
SCCA May Aid Pulmonary SCC Diagno­sis
  • Andrea Surnit
  • August 7, 2026
  • 4 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 7, 2026
EULAR Updates Guidance for PMR, LVV
  • Andrea Surnit
  • August 7, 2026
  • 5 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

MDSpire News

  • August 7, 2026
FDA Approves Viral Therapy Plus Nivolumab
  • Kathryn Wighton
  • August 7, 2026
  • 2 min
  1. The FDA approved vusolimogene oderparepvec-wtpg plus nivolumab for adults with unresectable advanced cutaneous melanoma.
  2. Approval was based on the objective response rate and duration observed in the IGNYTE trial involving 140 patients.
  3. In the trial, the objective response rate was 24.2%, with a median duration of response of 14.1 months.
  4. Replimune must conduct postapproval trials to verify the clinical benefit of the treatment combination.
  5. Warnings include risks of herpetic infection, injection complications, and various nonlaboratory adverse reactions.
...more

MDSpire News

  • August 7, 2026
Could Maternal RSV Vaccination Be the Preferred Option?
  • Andrea Surnit
  • August 7, 2026
  • 4 min
  1. Pregnant women and parents preferred maternal vaccination over infant antibody administration for RSV protection.
  2. Fifty-eight percent of pregnant women favored maternal vaccination, while only 6% preferred infant antibody shots.
  3. A strong physician recommendation increased vaccine acceptance among hesitant respondents, with 36% of initially negative pregnant women willing to reconsider.
  4. Concerns about vaccine safety for mothers and infants were the primary reasons for hesitancy among pregnant women.
  5. The survey highlighted information gaps and the need for improved communication strategies regarding RSV immunization.
...more

The Pathologist

  • August 7, 2026
The Gene That Helps Cancer Travel
  • August 7, 2026
  • 3 min
  1. CALB2 is identified as a gene linked to the survival of metastatic prostate cancer cells under mechanical stress in the bloodstream.
  2. The study involved exposing prostate cancer cell lines to high-intensity fluid shear stress, leading to the selection of mechanoresistant cells.
  3. In aggressive PC3 cells, CALB2 expression was significantly upregulated, contributing to their ability to withstand shear stress.
  4. Higher calretinin expression was found in prostate adenocarcinoma and metastatic tissue compared to adjacent normal tissue.
  5. The findings suggest CALB2 may serve as a biomarker for tumor adaptation to mechanical stress, warranting further research.
...more

The Pathologist

  • August 7, 2026
Building Stronger Laboratory Leaders
  • Brittany Teeter
  • August 7, 2026
  • 3 min
  1. Clinical laboratories face workforce shortages, regulatory changes, financial pressures, and evolving healthcare environments.
  2. Laboratory leaders must possess technical expertise along with skills in communication, strategic thinking, and team development.
  3. The ASCP CLMA enhances leadership capacity through education, engagement, and community building among laboratory professionals.
  4. Leadership-focused roundtable discussions facilitate peer-to-peer dialogue on practical solutions and emerging challenges.
  5. CLMA emphasizes the importance of local ASCP chapters for networking, mentorship, and professional development opportunities.
...more

The Medicine Maker

  • August 7, 2026
Musings from The Power List: Ali Pashazadeh
  • Ali Pashazadeh
  • August 7, 2026
  • 8 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 6, 2026
Senate Confirms New CDC Director
  • Kathryn Wighton
  • August 6, 2026
  • 3 min
  1. The Senate confirmed Erica Schwartz, MD, as the new director of the CDC with a vote of 51-44 on August 5.
  2. Schwartz is the second CDC director confirmed by the Senate since the confirmation requirement was established in 2023.
  3. The CDC had been without a confirmed director for nearly a year following the dismissal of Susan Monarez, MD.
  4. Schwartz faced questions during her confirmation hearing regarding her stance on public health decisions conflicting with HHS Secretary Kennedy.
  5. The CDC is currently addressing surges in measles, cyclosporiasis outbreaks, and an Ebola outbreak at the time of Schwartz's confirmation.
...more

MDSpire News

  • August 6, 2026
FDA Approves Oveporexton for Narcolepsy Type 1
  • Kathryn Wighton
  • August 6, 2026
  • 3 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 6, 2026
FDA Approves mRNA Flu Vaccine
  • Kathryn Wighton
  • August 6, 2026
  • 2 min
  1. The FDA approved Moderna's mFLUSIVA, the first mRNA-based influenza vaccine, for adults aged 50 years and older.
  2. mFLUSIVA is expected to be available in the US for the 2026 to 2027 respiratory virus season.
  3. FDA approval followed a unanimous recommendation from the Vaccines and Related Biological Products Advisory Committee.
  4. The approval for adults aged 65 years and older was granted based on a trial involving 2,992 participants in the US.
  5. Reported adverse events included injection-site reactions and systemic symptoms such as fatigue, headache, and muscle pain.
...more

Baptist Health South Florida

  • August 6, 2026
Baptist Health Orthopedic Care Physician Serves in Leadership Role at National Sports Medicine Conference
  • August 6, 2026
  • 1 min
  1. Baptist Health Orthopedic Care participated in the AOSSM Annual Meeting held from July 8-11 in Seattle.
  2. AOSSM is a leading organization focused on orthopedic sports medicine, promoting education, research, and clinical care.
  3. Dr. Gautam Yagnik served as the ICL chair on the Program Committee, contributing to the conference's educational programming.
  4. Dr. Yagnik presented at two sessions, including topics on high-stakes decisions and in-season management of contact athletes.
  5. Dr. Yagnik's roles highlight his expertise and Baptist Health Orthopedic Care's commitment to advancing orthopedic sports medicine.
...more

The Medicine Maker

  • August 6, 2026
What Did ASCO 2026 Reveal About the Future of Oncology?
  • James Strachan
  • August 6, 2026
  • 12 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 6, 2026
Medical Oddities: Shellfish Toxin? Send in the Frog
  • Teraya Smith
  • August 6, 2026
  • 4 min

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Take the Poll

MDSpire News

  • August 6, 2026
Video Game Design May Help Reduce Social Isolation Risk
  • Andrea Surnit
  • August 6, 2026
  • 3 min
  1. A study surveyed 529 adults in Japan to explore the relationship between hikikomori risk and video game preferences.
  2. No statistically significant differences in preferred video game genres were found between high and low hikikomori risk groups.
  3. Participants at higher risk preferred cooperative gameplay and were more sensitive to toxic online interactions.
  4. Qualitative findings highlighted a preference for immersive storytelling, strategic gameplay, and customizable experiences.
  5. The study suggests future game-based interventions should focus on cooperative play, narrative-driven experiences, and moderation of interactions.
...more